remdesivir
June 28, 2020 | Reuters
US to Ship Remdesivir to States With Rising COVID-19 Cases
NEW YORK—The U.S. government will ship more of Gilead Sciences Inc’s antiviral treatment remdesivir to states experiencing an increase in COVID-19 cases including California, Texas, Florida, and Arizona, according to the Department of Health and Human Services’ (HHS) website. The government reallocated remdesivir to states with increasing cases, White House task force coordinator Deborah Birx […]
May 23, 2020 | Reuters
NIH Trial: Gilead’s Drug Works Best in COVID Patients on Oxygen
The U.S. National Institutes of Health (NIH) on Friday said that data from its trial of Gilead Sciences Inc’s remdesivir show that the drug offers the most benefit for COVID-19 patients who need extra oxygen but do not require mechanical ventilation. The peer-reviewed data was published in the New England Journal of Medicine. The trial, […]
May 1, 2020 | Jack Phillips
FDA Allows Emergency Use of Remdesivir to Treat CCP Virus Patients, Trump Says
The Food and Drug Administration (FDA) granted an emergency authorization for Gilead’s remdesivir to treat the CCP virus, said President Donald Trump on Friday. Trump made the announcement alongside Gilead’s CEO, Daniel O’Day, saying that it is “an important treatment for hospitalized coronavirus patients … it’s really a promising situation.” “We want to thank the collaborators that […]
April 6, 2020 | Katabella Roberts
Gilead Sciences Donates 1.5 Million Doses of Experimental Drug to Virus Patients With Severe Symptoms
U.S. biotechnology firm Gilead Sciences has announced it will be donating 1.5 million doses of its experimental anti-CCP virus drug, remdesivir, for compassionate use, expanded access, and clinical trials. The doses are intended for patients with severe symptoms of CCP virus, commonly known as novel coronavirus, who will receive them through daily intravenous infusions in a hospital setting. They […]